Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 339

1.

Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.

Bello DM, Panageas KS, Hollmann T, Shoushtari AN, Momtaz P, Chapman PB, Postow MA, Callahan MK, Wolchok JD, Brady MS, Coit DG, Ariyan CE.

Ann Surg Oncol. 2019 Dec 17. doi: 10.1245/s10434-019-08099-9. [Epub ahead of print]

PMID:
31848819
2.

High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy.

Bartlett EK, Flynn JR, Panageas KS, Ferraro RA, Sta Cruz JM, Postow MA, Coit DG, Ariyan CE.

Cancer. 2020 Jan 1;126(1):76-85. doi: 10.1002/cncr.32506. Epub 2019 Oct 4.

PMID:
31584709
3.

A Metamodeling Framework for Quantifying Health Damages of Power Grid Expansion Plans.

Rodgers MD, Coit DW, Felder FA, Carlton AG.

Int J Environ Res Public Health. 2019 May 26;16(10). pii: E1857. doi: 10.3390/ijerph16101857.

4.

The Changing Kinetics of Advanced Melanoma.

Coit DG.

JAMA Dermatol. 2019 Jun 1;155(6):657-659. doi: 10.1001/jamadermatol.2019.0200. No abstract available.

PMID:
31042261
5.

Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype.

Kim TS, da Silva E, Coit DG, Tang LH.

Am J Surg Pathol. 2019 Jun;43(6):851-860. doi: 10.1097/PAS.0000000000001253.

PMID:
30969179
6.

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Coit DG, Thompson JA, Albertini MR, Barker C, Carson WE, Contreras C, Daniels GA, DiMaio D, Fields RC, Fleming MD, Freeman M, Galan A, Gastman B, Guild V, Johnson D, Joseph RW, Lange JR, Nath S, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Wuthrick E, McMillian NR, Engh AM.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):367-402. doi: 10.6004/jnccn.2019.0018.

PMID:
30959471
7.

Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre and Post-imatinib Eras.

Cavnar MJ, Seier K, Curtin C, Balachandran VP, Coit DG, Yoon SS, Crago AM, Strong VE, Tap WD, Gönen M, Antonescu CR, Brennan MF, Singer S, DeMatteo RP.

Ann Surg. 2019 Apr 2. doi: 10.1097/SLA.0000000000003277. [Epub ahead of print]

PMID:
30946076
8.

Prevalence of False-Negative Results of Intraoperative Consultation on Surgical Margins During Resection of Gastric and Gastroesophageal Adenocarcinoma.

McAuliffe JC, Tang LH, Kamrani K, Olino K, Klimstra DS, Brennan MF, Coit DG.

JAMA Surg. 2019 Feb 1;154(2):126-132. doi: 10.1001/jamasurg.2018.3863.

9.

Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study.

Cassidy MR, Lefkowitz RA, Long N, Qin LX, Kirane A, Sbaity E, Hameed M, Coit DG, Brennan MF, Singer S, Crago AM.

Ann Surg. 2018 Nov 9. doi: 10.1097/SLA.0000000000003073. [Epub ahead of print]

PMID:
30418203
10.

Comparison of gastric cancer survival after R0 resection in the US and China.

Li P, Huang CM, Zheng CH, Russo A, Kasbekar P, Brennan MF, Coit DG, Strong VE.

J Surg Oncol. 2018 Nov;118(6):975-982. doi: 10.1002/jso.25220. Epub 2018 Oct 17.

11.

Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers.

Mori S, Navarrete-Dechent C, Petukhova TA, Lee EH, Rossi AM, Postow MA, Dunn LA, Roman BR, Yin VT, Coit DG, Hollmann TJ, Busam KJ, Nehal KS, Barker CA.

J Natl Compr Canc Netw. 2018 Oct;16(10):1209-1215. doi: 10.6004/jnccn.2018.7044.

12.

Metastatic squamous cell carcinoma of known and unknown primary origin treated with axillary or inguinal lymphadenectomy.

Wach MM, van Beek E, Ayabe R, Ruff S, Brown Z, Goldman DA, Zambirinis CP, Gholami S, Pulitzer M, Hernandez J, Coit D.

Am J Surg. 2018 Nov;216(5):963-968. doi: 10.1016/j.amjsurg.2018.06.006. Epub 2018 Jun 20.

PMID:
30143231
13.

MelMART Trial: It's Now or Never.

Coit D, Ariyan C.

Ann Surg Oncol. 2018 Sep;25(9):2493-2495. doi: 10.1245/s10434-018-6573-8. Epub 2018 Jun 26. No abstract available.

PMID:
29946999
14.

Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease.

Russo AE, Untch BR, Kris MG, Chou JF, Capanu M, Coit DG, Chaft JE, D'Angelica MI, Brennan MF, Strong VE.

Ann Surg. 2019 Aug;270(2):373-377. doi: 10.1097/SLA.0000000000002749.

PMID:
29578911
15.

Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors.

Zabor EC, Coit D, Gershenwald JE, McMasters KM, Michaelson JS, Stromberg AJ, Panageas KS.

Ann Surg Oncol. 2018 Aug;25(8):2172-2177. doi: 10.1245/s10434-018-6370-4. Epub 2018 Feb 22.

16.

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.

Rosner S, Kwong E, Shoushtari AN, Friedman CF, Betof AS, Brady MS, Coit DG, Callahan MK, Wolchok JD, Chapman PB, Panageas KS, Postow MA.

Cancer Med. 2018 Mar;7(3):690-697. doi: 10.1002/cam4.1356. Epub 2018 Feb 22.

17.

Response to the Letter to the Editor by CM den Bakker and DL van Der Peet.

Coit DG, Hernandez J, Schoder H, Goldman D.

Ann Surg. 2018 Dec;268(6):e79-e80. doi: 10.1097/SLA.0000000000002676. No abstract available.

PMID:
29334563
18.

Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation.

Momtaz P, Harding JJ, Ariyan C, Coit DG, Merghoub T, Gasmi B, You D, Viale A, Panageas KS, Samoila A, Postow MA, Wolchok JD, Chapman PB.

Oncotarget. 2017 Sep 16;8(62):105000-105010. doi: 10.18632/oncotarget.21072. eCollection 2017 Dec 1.

19.

Future cancer research priorities in the USA: a Lancet Oncology Commission.

Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A.

Lancet Oncol. 2017 Nov;18(11):e653-e706. doi: 10.1016/S1470-2045(17)30698-8. Epub 2017 Oct 31. Review.

20.

Transected thin melanoma: Implications for sentinel lymph node staging.

Herbert G, Karakousis GC, Bartlett EK, Zaheer S, Graham D, Czerniecki BJ, Fraker DL, Ariyan C, Coit DG, Brady MS.

J Surg Oncol. 2018 Mar;117(4):567-571. doi: 10.1002/jso.24930. Epub 2017 Nov 30.

21.
22.

Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.

Janjigian YY, Sanchez-Vega F, Jonsson P, Chatila WK, Hechtman JF, Ku GY, Riches JC, Tuvy Y, Kundra R, Bouvier N, Vakiani E, Gao J, Heins ZJ, Gross BE, Kelsen DP, Zhang L, Strong VE, Schattner M, Gerdes H, Coit DG, Bains M, Stadler ZK, Rusch VW, Jones DR, Molena D, Shia J, Robson ME, Capanu M, Middha S, Zehir A, Hyman DM, Scaltriti M, Ladanyi M, Rosen N, Ilson DH, Berger MF, Tang L, Taylor BS, Solit DB, Schultz N.

Cancer Discov. 2018 Jan;8(1):49-58. doi: 10.1158/2159-8290.CD-17-0787. Epub 2017 Nov 9.

23.

Comparison of Young Patients with Gastric Cancer in the United States and China.

Strong VE, Russo A, Yoon SS, Brennan MF, Coit DG, Zheng CH, Li P, Huang CM.

Ann Surg Oncol. 2017 Dec;24(13):3964-3971. doi: 10.1245/s10434-017-6073-2. Epub 2017 Oct 19.

PMID:
29052085
24.

Endoscopic Ultrasound as a Pretreatment Clinical Staging Tool for Gastric Cancer: Association with Pathology and Outcome.

Merkow RP, Herrera G, Goldman DA, Gerdes H, Schattner MA, Markowitz AJ, Strong VE, Brennan MF, Coit DG.

Ann Surg Oncol. 2017 Nov;24(12):3658-3666. doi: 10.1245/s10434-017-6050-9. Epub 2017 Aug 16.

PMID:
28815443
25.

Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma.

Hernandez JM, Beylergil V, Goldman DA, van Beek E, Gonen M, Tang L, Downey R, Rizk N, Shah M, Strong V, Janjigian Y, Schöder H, Coit DG.

Ann Surg. 2018 May;267(5):898-904. doi: 10.1097/SLA.0000000000002306.

26.

Global Forum of Cancer Surgeons: Declaration of Intent.

Are C, Coit DG, McMasters KM, Giuliano AE, Anderson BO, Balch CM, Pathak KA, Audisio RA, Rubio IT, Gonzalez-Moreno S, Mori M, Eguchi H, Savant D, Prasad BKCM, Cheema MA, Chaudhry ZA, Yang HK, Park DJ, Coimbra FJF, Quadros C, Said HM, Bargallo-Rocha JE.

Ann Surg Oncol. 2017 Sep;24(9):2429-2431. doi: 10.1245/s10434-017-5951-y. Epub 2017 Jul 5. No abstract available.

PMID:
28676922
27.

The Enigma of Regional Lymph Nodes in Melanoma.

Coit D.

N Engl J Med. 2017 Jun 8;376(23):2280-2281. doi: 10.1056/NEJMe1704290. No abstract available.

PMID:
28591534
28.

Society of Surgical Oncology Presidential Address: Seattle, WA, USA, March 17, 2017 : The Future Ain't What it Used to Be.

Coit DG.

Ann Surg Oncol. 2017 Aug;24(8):2055-2064. doi: 10.1245/s10434-017-5892-5. Epub 2017 May 25. No abstract available.

PMID:
28547564
29.

Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.

Freites-Martinez A, Kwong BY, Rieger KE, Coit DG, Colevas AD, Lacouture ME.

JAMA Dermatol. 2017 Jul 1;153(7):694-697. doi: 10.1001/jamadermatol.2017.0989.

30.

Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment.

Cassidy MR, Wolchok RE, Zheng J, Panageas KS, Wolchok JD, Coit D, Postow MA, Ariyan C.

EBioMedicine. 2017 Apr;18:56-61. doi: 10.1016/j.ebiom.2017.03.029. Epub 2017 Mar 24.

31.

Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.

Davis JL, Langan RC, Panageas KS, Zheng J, Postow MA, Brady MS, Ariyan C, Coit DG.

Ann Surg Oncol. 2017 Jul;24(7):1989-1996. doi: 10.1245/s10434-017-5836-0. Epub 2017 Mar 16.

32.

Reduced H3K27me3 expression in Merkel cell polyoma virus-positive tumors.

Busam KJ, Pulitzer MP, Coit DC, Arcila M, Leng D, Jungbluth AA, Wiesner T.

Mod Pathol. 2017 Jun;30(6):877-883. doi: 10.1038/modpathol.2017.8. Epub 2017 Mar 10.

33.

Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.

Pak LM, Coit DG, Eaton AA, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Strong VE, Kingham TP.

Ann Surg Oncol. 2017 May;24(5):1174-1179. doi: 10.1245/s10434-016-5757-3. Epub 2017 Jan 5.

34.

CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice Site.

Yelskaya Z, Bacares R, Salo-Mullen E, Somar J, Lehrich DA, Fasaye GA, Coit DG, Tang LH, Stadler ZK, Zhang L.

PLoS One. 2016 Nov 23;11(11):e0165654. doi: 10.1371/journal.pone.0165654. eCollection 2016.

35.

Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.

Lee AY, Droppelmann N, Panageas KS, Zhou Q, Ariyan CE, Brady MS, Chapman PB, Coit DG.

Ann Surg Oncol. 2017 Apr;24(4):939-946. doi: 10.1245/s10434-016-5642-0. Epub 2016 Nov 1.

36.

Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.

Strong VE, Gholami S, Shah MA, Tang LH, Janjigian YY, Schattner M, Selby LV, Yoon SS, Salo-Mullen E, Stadler ZK, Kelsen D, Brennan MF, Coit DG.

Ann Surg. 2017 Dec;266(6):1006-1012. doi: 10.1097/SLA.0000000000002030.

PMID:
27759617
37.

Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor.

Lee SY, Goh BK, Sadot E, Rajeev R, Balachandran VP, Gönen M, Kingham TP, Allen PJ, D'Angelica MI, Jarnagin WR, Coit D, Wong WK, Ong HS, Chung AY, DeMatteo RP.

Ann Surg Oncol. 2017 Jan;24(1):202-210. doi: 10.1245/s10434-016-5565-9. Epub 2016 Sep 13.

38.

Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience.

Won E, Shah MA, Schöder H, Strong VE, Coit DG, Brennan MF, Kelsen DP, Janjigian YY, Tang LH, Capanu M, Rizk NP, Allen PJ, Bains MS, Ilson DH.

J Gastrointest Oncol. 2016 Aug;7(4):506-14. doi: 10.21037/jgo.2016.06.01.

39.

Training a new generation of surgeons worldwide who are also oncologists.

Balch CM, Poston GJ, Coit D, Audisio R.

Chin Clin Oncol. 2016 Aug;5(4):58. doi: 10.21037/cco.2016.07.02. No abstract available.

40.

A peripheral blood biomarker estimates probability of survival: the neutrophil-lymphocyte ratio in noncancer patients.

Davis JL, Moutinho V Jr, Panageas KS, Coit DG.

Biomark Med. 2016 Sep;10(9):953-7. doi: 10.2217/bmm-2016-0103. Epub 2016 Aug 18.

41.

NCCN Guidelines Insights: Melanoma, Version 3.2016.

Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Fields RC, Fleming MD, Gastman B, Gonzalez R, Guild V, Johnson D, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A.

J Natl Compr Canc Netw. 2016 Aug;14(8):945-58.

PMID:
27496110
42.

Molecular Profiling of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone.

Gulati N, Garcet S, Fuentes-Duculan J, Gilleaudeau P, Sullivan-Whalen M, Li X, Suárez-Fariñas M, Coit DG, Krueger JG.

J Invest Dermatol. 2016 Oct;136(10):2101-2103. doi: 10.1016/j.jid.2016.06.611. Epub 2016 Jul 1. No abstract available.

43.

Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer.

Kelly KJ, Wong J, Gönen M, Allen P, Brennan M, Coit D, Fong Y.

EBioMedicine. 2016 May;7:94-9. doi: 10.1016/j.ebiom.2016.03.043. Epub 2016 Apr 2.

44.

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.

Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz P, Ariyan CE, Brady MS, Coit DG, Bogatch K, Callahan MK, Wolchok JD, Carvajal RD, Postow MA.

Oncologist. 2016 Jul;21(7):848-54. doi: 10.1634/theoncologist.2015-0522. Epub 2016 Jun 10.

45.

Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Ernstoff M, Fields RC, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS Jr, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A.

J Natl Compr Canc Netw. 2016 Apr;14(4):450-73.

PMID:
27059193
46.

NCCN Guidelines and Quality Cancer Care: Where Have We Come From, and Where Should We Be Going?

Coit DG.

J Natl Compr Canc Netw. 2016 Apr;14(4):373-7. No abstract available.

PMID:
27059186
47.

Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.

Cao L, Selby LV, Hu X, Zhang Y, Janjigian YY, Tang L, Coit DG, Brennan MF, Strong VE.

J Surg Oncol. 2016 Jun;113(7):745-9. doi: 10.1002/jso.24228. Epub 2016 Apr 4.

48.

Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project.

Sano T, Coit DG, Kim HH, Roviello F, Kassab P, Wittekind C, Yamamoto Y, Ohashi Y.

Gastric Cancer. 2017 Mar;20(2):217-225. doi: 10.1007/s10120-016-0601-9. Epub 2016 Feb 20.

49.

Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation.

Busam KJ, Vilain RE, Lum T, Busam JA, Hollmann TJ, Saw RP, Coit DC, Scolyer RA, Wiesner T.

Am J Surg Pathol. 2016 Jun;40(6):786-95. doi: 10.1097/PAS.0000000000000611.

50.

2015 James Ewing Lecture: 75-Year History of the Society of Surgical Oncology-Part III: The Transformative Years (1991-2015).

Balch CM, Coit DG, Berman RS.

Ann Surg Oncol. 2016 May;23(5):1409-17. doi: 10.1245/s10434-015-5011-4. Epub 2016 Jan 28. No abstract available.

PMID:
26822879

Supplemental Content

Support Center